Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin.
about
Antibiotics for community-acquired pneumonia in adult outpatientsEmpiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adultsAntibiotics for community acquired pneumonia in adult outpatientsEmpiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adultsRespiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trialsDuration of antimicrobial therapy in community acquired pneumonia: less is moreFluoroquinolones in the management of community-acquired pneumonia in primary care.Efficacy and safety of nemonoxacin versus levofloxacin for community-acquired pneumoniaEffectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis.Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis.Role of gemifloxacin in community-acquired pneumonia.Strategies for reduction in duration of antibiotic use in hospitalized patients.Treatment of community-acquired pneumonia, with special emphasis on gemifloxacin.The Value of Macrolide-Based Regimens for Community-Acquired Pneumonia.Risk factors for drug-resistant Streptococcus pneumoniae and antibiotic prescribing practices in outpatient community-acquired pneumonia.Are fluoroquinolones superior antibiotics for the treatment of community-acquired pneumonia?Top Questions in Uncomplicated, Non-Staphylococcus aureus Bacteremia.
P2860
Q24193127-93AF6B9F-E97F-40B0-9064-A653D48E8A63Q24200609-A329921C-0937-4F0C-AF94-B6CD4F19F7ECQ24240033-2B8A95A8-DB9C-4087-BC45-E0AB3555718FQ24242728-1A945033-D68C-4907-A56F-EC80AB188906Q24655866-500CFDAD-5581-44CB-83A4-CFD4C5DC1DD7Q26828493-A50AC8DC-D22E-49AA-82D8-04E6684091EBQ30452249-F3E71E5B-C983-4F7D-AAD8-ECAD512A26D7Q34151093-FD5FE85D-6C89-4226-B21F-AF25D085EBB4Q36026172-DCBE3D04-27F6-431F-A83C-046CA4A637FBQ36391382-498BAEAA-ED9A-4D63-9FCD-DEF440A309BAQ37228717-53ADCCF9-C6A8-40AD-9733-0EFCF956782EQ37867329-24FC9F77-D52C-4A0A-A0CA-F7ADD7E47058Q38523119-B64535F3-D079-4640-BC1D-CAC4836CEF23Q38601840-E66BA532-09D6-4897-B3B8-9477B1FF5756Q40037241-D7E4ED72-17B4-4099-87DD-3D7E20868CE3Q48023992-6F2ADBE4-84DF-435C-8CE2-4D32EFDC8257Q55039125-939CF8BC-47C9-40BA-9C57-96607985767D
P2860
Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Gemifloxacin once daily for 7 ...... suspected pneumococcal origin.
@ast
Gemifloxacin once daily for 7 ...... suspected pneumococcal origin.
@en
Gemifloxacin once daily for 7 ...... suspected pneumococcal origin.
@nl
type
label
Gemifloxacin once daily for 7 ...... suspected pneumococcal origin.
@ast
Gemifloxacin once daily for 7 ...... suspected pneumococcal origin.
@en
Gemifloxacin once daily for 7 ...... suspected pneumococcal origin.
@nl
prefLabel
Gemifloxacin once daily for 7 ...... suspected pneumococcal origin.
@ast
Gemifloxacin once daily for 7 ...... suspected pneumococcal origin.
@en
Gemifloxacin once daily for 7 ...... suspected pneumococcal origin.
@nl
P2093
P1433
P1476
Gemifloxacin once daily for 7 ...... suspected pneumococcal origin.
@en
P2093
P304
P356
10.1016/J.RMED.2004.04.007
P577
2004-08-01T00:00:00Z